Skip to content
← Myeloproliferative Neoplasms

FOR PATIENTS · SOURCE READING

Certain factors affect prognosis (chance of recovery) and treatment options for primary myelofibrosis.

Source: Myeloproliferative Neoplasms Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 12, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

The prognosis depends on:

Source links and citations

the age of the patient

the number of abnormal red blood cells and white blood cells

Source links and citations

the number of blasts in the blood

whether there are certain changes in the chromosomes

Source links and citations

whether the patient has signs such as fever, drenching night sweats, or weight loss

Preserved source evidence · Independent clinical review pending · Not medical advice